Qube Research & Technologies (QRT)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-56,200
Closed -$5.06M 3933
2024
Q4
$5.06M Hold
56,200
0.01% 1494
2024
Q3
$5.55M Buy
56,200
+1,600
+3% +$157K 0.01% 1336
2024
Q2
$5.06M Sell
54,600
-38,400
-41% -$3.44M 0.01% 1244
2024
Q1
$8.82M Buy
+93,000
New +$8.63M 0.01% 917
2023
Q4
Sell
-33,400
Closed -$2.44M 4802
2023
Q3
$2.44M Buy
+33,400
New +$2.67M 0.01% 1275

Other funds holding XBI

Qube Research & Technologies (QRT)'s XBI Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 146% in Q1 2026, buying an estimated $14.1M and bringing the position to 190,717 shares worth $24.4M. The position accounts for 0.03% of the portfolio, ranked #770.

Qube Research & Technologies (QRT) first reported a position in XBI in Q1 2020 and has held it in 17 quarters since. The position peaked at $28.6M in Q4 2020. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Qube Research & Technologies (QRT) held 190,717 shares of State Street SPDR S&P Biotech ETF worth $24.4M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 113,217 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $14.1M.
  • State Street SPDR S&P Biotech ETF made up 0.03% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #770 holding.
  • Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 17 quarters since.
  • Qube Research & Technologies (QRT)'s State Street SPDR S&P Biotech ETF position peaked at $28.6M in Q4 2020.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.